Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1995-04-17
1997-09-23
Nucker, Christine M.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
435 71, 435 79, 435 791, 435 792, 435 793, 435 794, 435 795, 530324, 530325, 530326, 530826, C12Q 170
Patent
active
056703112
ABSTRACT:
Peptides corresponding to epitopes of HTLV-2 proteins are provided. These peptides are immunologically reactive with HTLV-2 specific antibodies. Several of the peptides are sufficiently unreactive to antibodies to HTLV-1 to distinguish between antibodies which recognize HTLV-1 and those which recognize HTLV-2. Thus HTLV-1 infections can be distinguished from HTLV-2 infections. The peptides are useful in assays for detection of HTLV-2 infection or exposure. The peptides are also useful as vaccine compositions against HTLV-2. Antibodies generated in response to immunization by the peptides are also provided.
REFERENCES:
patent: 4833071 (1989-05-01), Wang et al.
patent: 5003043 (1991-03-01), Akita et al.
"Solid Phase Peptide Snythesis" Erickson, et al., The Proteins, 3rd Edition vol. 2, Chapter 3, pp. 255-527, 1976.
"Solid Phase Peptide Synthesis" Barany, et al., The Peptides vol. 2, Chapter 1, pp.1-284, 1979.
"The Development of Synthetic Vaccines" Lerner, et al., The Biology of Immunologic Disease, pp. 331-338, 1983, ed. by Dixon & Fisher pub. by Sinauer Assoc. Inc.
Seiki, et al., Proc. National Academy of Science, 80:3618-3622, 1983.
"Antibodies of Predetermined Specificity in Biology and Medicine" Lerner, Advances in Immunology, 36:1-44, 1984.
"Human T-Cell Leukemia Virus: Its Discovery and Role in Leukemogenesis and Immunosuppression" Shaw, et al., (Publication Unknown), pp. 1-27, published by Year Book Medical Publisher, Inc. 1984.
"Sequence of the Envelope Gycoprotein Gene of Type II Humas I Lymphotropic Virus" Sodroski, et al., Science, pp. 421-424, 1984.
"Low Prevalence in the UK of HTLV-I and HTLV-II Infection in Subject with AIDS, With Extended Lymphadenopathy, and at Risk of AIDS" Tedder, et al., The Lancet, pp. 125-127, Jul. 21, 1984.
"Complete Nucleotide Sequence of an Infections Clone of Human T-Cell Leukemia Virus Type II: An Open Reading Frame for the Protease Gene" Shimotohno, et al., Proc. Natl. Acad. Sci., 82:3101-3105, May 1985.
"Detection if Antibodies to Human T-Cell Lymphotrophic Virus-III (HTLV-III) With an Immunoassay Employing a Recombinant Escherichia Coli-Derived Viral Antigenic Peptide" Chang, et al., Bio/Technology, 3:905-909, Oct. 1985.
"HTLV-I and HTLV-III Antibodies and Tropical Spastic Paraparesis" Rodgers-Johnson, et al., Lancet, 1247-1248, Nov. 30, 1985.
"Human T-Cell Leukemia Viruses" Sarngadharan, et al., Virology, Chapter 58:1345-1371, 1985.
"Prevalence of Antibodies to HTLV-I, -II, and -III in Intravenous Drub Abusers From AIDS Endemic Region" Robert-Guroff, et al., Jama, 255: No. 22, pp. 3133-3137, Jun. 13, 1986.
"Aids Virus env Protein Expressed From a Recombinant Vaccinia Virus" Kieny, et al., Bio/Technology, 4:790-795, Sep. 1986.
"HTLV-III/LAV-Neutralizing Antibodies to an E. coli-Produced Fragment of the Virus Envelope" Putney, et al., Science, 234:1392-1395, Dec. 12, 1986.
"Serodiagnosis of Antibodies to the Human AIDS Retrovirus With a Bacterially Synthesized env Polypeptide" Cabradilla, et al., Biotechnology, 4:128-133, Feb. 1986.
"A Second Isolate of HTLV-II Associated with Atypical Hairy-Cell Leukemia" Rosenblatt, et al., New England Journal of Medicine, 315: No. 6, pp. 372-377, Aug. 7, 1986.
"Endemic Tropical Spastic Paraparesis Associated With Human T-Lymphotropic Virus Type I: A Clinical and Seroepidemiological Study of 25 Cases" Vernant, et al., Annals of Neurology, 21: No. 2, pp. 123-130, Feb. 1987.
"Leukemia Virus Linked to Nerve Disease" Marx, Science, 236:1059-1061, May 29, 1987.
"Sensitivity and Specificity of Commercial ELISA Kits for Sreening Anti-LAV/HTLV III" Gurtler, et al., Journal of Virological Methods, 15:11-23, 1987.
"Integrated Human T-Cell Leukemia Virus II Genome in CD8+T Cells From a Patient With `Atypical`Hairy Cell Leukemia: Evidence of Distinct T and B Cell Lumphoproliferative Disorders" Rosenblatt, et al., Blood, 71:363-369, Feb. 1988.
"Comparison of Immunofluorescence, Enzyme Immunoassay, and Western Blot (Immunoblot) Methods for Detection of Antibody to Human T-Cell Leukemia Virus Type I" Gallo, et al., Journal of Clinical Microbiology, 26:1487-1491, Aug. 1988.
"High Rate of HTLV -II Infection in Seropositive IV Drug Abusers in New Orleans" Lee, et al., Science, 244:471-475, Apr. 28, 1989.
Sodroski et al, "Sequence of the Envelope Glycoprotein Gene of Type II Human T Lymphotropic Virus" Science, vol. 225, 27 Jul. 1984, pp. 421-424.
Horal Peter
Jeansson Stig
Rymo Lars
Svennerholm Bo
Vahlne Anders
Maxim Pharmaceuticals, Inc.
Nucker Christine M.
Stucker Jeffrey
LandOfFree
Peptides for detecting antibodies to HTLV-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides for detecting antibodies to HTLV-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for detecting antibodies to HTLV-2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1938238